New Delhi/Hyderabad: Dr Reddys Laboratories, which soft-launched Russia’s Covid-19 vaccine, Sputnik V on May 14 has expanded the pilot project to over 50 other cities and towns in the country. The company also assures to strengthen the commercial roll-out of Sputnik V vaccines in the coming weeks.
In a tweet, late Monday, Hyderabad based drugmaker said, “Starting initially in Hyderabad today, the soft launch rollout of Sputnik V has scaled up speedily and reached cities and towns all over India- including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik.”
— Dr. Reddy's (@drreddys) July 12, 2021
Other cities include–Coimbatore, Ranchi, Jaipur, Lucknow, Patna, Bhubaneshwar, Guwahati, Thiruvananthapuram, Ahmedabad, Rajkot, Palakkad, Allahabad, Dimapur, Kohima, Indore, Bhopal, Surat, Cuttack, Dharwad, Ernakulum, Ratlam, Faridabad, Srinagar, Gandhinagar, Vadodara, Gulbarga, Madurai, Guntur, Kannur, Jabalpur, Jalandhar, Kanpur, and Mysore.
“We will strengthen the commercial roll-out of Sputnik V in the coming weeks. Neither the ongoing soft commercial launch nor work towards its ramp-up in India has been put on hold,” said Dr Reddy’s Laboratories added in a statement on the Sputnik V vaccine in India.
Dr Reddy’s has partnered with major hospitals across the country for this purpose, all of whom have successfully administered Sputnik V in India, including ongoing commercial roll-outs to the public.
Recently, Dr Reddy’s received nearly three million doses of SputnikV from the Russian Direct Investment Fund with which it has a pact to sell 125 million people doses (250 million vials) in India. The Indian drug regulator has granted permission for restricted emergency use of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.
Dr Reddy’s have received 3 million vials of first dose by June 1, while only 360,000 vials of the second dose by the early this month, the government of India and the company informed. This has led to a delay in the commercial rollout of the Sputnik V Covid-19 vaccine as the Russian producer of the vaccine has yet to provide equal quantities of its two differing doses.
The Sputnik V vaccine was launched on a soft pilot basis in India on May 14, 2021. The nationwide soft launch of Sputnik V has reached over 50 cities and towns across India.
(With inputs from ANI and PTI)